CYP2E1 and Parkinson disease: Western blot analysis suggested increased expression of CYP2E1 protein in the brains of PD patients compared with those of controls (control: 0.13 ± 0.07 vs. PD: 0.42 ± 0.21; p = 0.042; mean ± SD; Figure 2I).